BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed LABT catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:af491f819b60fc765458@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:LABT P2 readout (est.): Phase 2a Dose Finding Study of Nu-3 Gel in 
 Subjects With Mild iDFU
DESCRIPTION:Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild i
 DFU\nNCT07565506 | PHASE2 | RECRUITING | sponsor: Lakewood-Amedex Inc\nPri
 mary completion date (ESTIMATED)\; top-line results usually follow later.\
 nDate precision: month (shown on the first day)\nTicker LABT (confidence 0
 .9)\nSource: https://clinicaltrials.gov/study/NCT07565506\nScheduling/refe
 rence data from public records\; dates can move. Not investment\, legal or
  medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT07565506
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
